Global Intravenous Injection General Anesthesia Drugs Supply, Demand and Key Producers, 2024-2030
Page: 139
Published Date: 17 Feb 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
- Description
- Table of Contents
- Table of Figures
- Research Methodology
- Companies Mentioned
- Related Reports
- Product Tags
Description
The global Intravenous Injection General Anesthesia Drugs market size is expected to reach $ 2455.4 million by 2030, rising at a market growth of 6.0% CAGR during the forecast period (2024-2030).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Intravenous general anesthesia refers to a method in which one or several drugs are injected intravenously and act on the central nervous system through blood circulation to produce general anesthesia. According to different administration methods, intravenous anesthesia can be divided into single administration method, divided administration method and continuous administration method. Due to some limitations of its own, the use of intravenous general anesthesia was once limited. However, since the 1980s, with the continuous improvement of clinical pharmacology research methods, the development of new strong and short-acting intravenous anesthetics and the advent of computerized intravenous automatic drug delivery systems, intravenous anesthesia has been greatly improved. And development, has now become the mainstream general anesthesia solution.
This report studies the global Intravenous Injection General Anesthesia Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Intravenous Injection General Anesthesia Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Intravenous Injection General Anesthesia Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Intravenous Injection General Anesthesia Drugs total production and demand, 2019-2030, (K Units)
Global Intravenous Injection General Anesthesia Drugs total production value, 2019-2030, (USD Million)
Global Intravenous Injection General Anesthesia Drugs production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Intravenous Injection General Anesthesia Drugs consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Intravenous Injection General Anesthesia Drugs domestic production, consumption, key domestic manufacturers and share
Global Intravenous Injection General Anesthesia Drugs production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Intravenous Injection General Anesthesia Drugs production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Intravenous Injection General Anesthesia Drugs production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Intravenous Injection General Anesthesia Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aspen Pharma, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Maruishi, Piramal, Hikma Pharmaceuticals and AstraZeneca, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Intravenous Injection General Anesthesia Drugs market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Intravenous Injection General Anesthesia Drugs Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Intravenous Injection General Anesthesia Drugs Market, Segmentation by Type
Propofol
Sevoflurane
Remifentanil
Etomidate
Isoflurane
Other
Global Intravenous Injection General Anesthesia Drugs Market, Segmentation by Application
Hopitals
Clinics
Others
Companies Profiled:
Aspen Pharma
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
AstraZeneca
Nhwa
Hengrui
Xi'an Libang
Yichang Humanwell
China National Medicines Guorui Pharmaceutical Co.,Ltd.
Maruishi
Lunan Pharmaceutical Group Corporation
Key Questions Answered
1. How big is the global Intravenous Injection General Anesthesia Drugs market?
2. What is the demand of the global Intravenous Injection General Anesthesia Drugs market?
3. What is the year over year growth of the global Intravenous Injection General Anesthesia Drugs market?
4. What is the production and production value of the global Intravenous Injection General Anesthesia Drugs market?
5. Who are the key producers in the global Intravenous Injection General Anesthesia Drugs market?
Table of Contents
1 Supply Summary
1.1 Intravenous Injection General Anesthesia Drugs Introduction
1.2 World Intravenous Injection General Anesthesia Drugs Supply & Forecast
1.2.1 World Intravenous Injection General Anesthesia Drugs Production Value (2019 & 2023 & 2030)
1.2.2 World Intravenous Injection General Anesthesia Drugs Production (2019-2030)
1.2.3 World Intravenous Injection General Anesthesia Drugs Pricing Trends (2019-2030)
1.3 World Intravenous Injection General Anesthesia Drugs Production by Region (Based on Production Site)
1.3.1 World Intravenous Injection General Anesthesia Drugs Production Value by Region (2019-2030)
1.3.2 World Intravenous Injection General Anesthesia Drugs Production by Region (2019-2030)
1.3.3 World Intravenous Injection General Anesthesia Drugs Average Price by Region (2019-2030)
1.3.4 North America Intravenous Injection General Anesthesia Drugs Production (2019-2030)
1.3.5 Europe Intravenous Injection General Anesthesia Drugs Production (2019-2030)
1.3.6 China Intravenous Injection General Anesthesia Drugs Production (2019-2030)
1.3.7 Japan Intravenous Injection General Anesthesia Drugs Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Intravenous Injection General Anesthesia Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Intravenous Injection General Anesthesia Drugs Major Market Trends
2 Demand Summary
2.1 World Intravenous Injection General Anesthesia Drugs Demand (2019-2030)
2.2 World Intravenous Injection General Anesthesia Drugs Consumption by Region
2.2.1 World Intravenous Injection General Anesthesia Drugs Consumption by Region (2019-2024)
2.2.2 World Intravenous Injection General Anesthesia Drugs Consumption Forecast by Region (2025-2030)
2.3 United States Intravenous Injection General Anesthesia Drugs Consumption (2019-2030)
2.4 China Intravenous Injection General Anesthesia Drugs Consumption (2019-2030)
2.5 Europe Intravenous Injection General Anesthesia Drugs Consumption (2019-2030)
2.6 Japan Intravenous Injection General Anesthesia Drugs Consumption (2019-2030)
2.7 South Korea Intravenous Injection General Anesthesia Drugs Consumption (2019-2030)
2.8 ASEAN Intravenous Injection General Anesthesia Drugs Consumption (2019-2030)
2.9 India Intravenous Injection General Anesthesia Drugs Consumption (2019-2030)
3 World Intravenous Injection General Anesthesia Drugs Manufacturers Competitive Analysis
3.1 World Intravenous Injection General Anesthesia Drugs Production Value by Manufacturer (2019-2024)
3.2 World Intravenous Injection General Anesthesia Drugs Production by Manufacturer (2019-2024)
3.3 World Intravenous Injection General Anesthesia Drugs Average Price by Manufacturer (2019-2024)
3.4 Intravenous Injection General Anesthesia Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Intravenous Injection General Anesthesia Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Intravenous Injection General Anesthesia Drugs in 2023
3.5.3 Global Concentration Ratios (CR8) for Intravenous Injection General Anesthesia Drugs in 2023
3.6 Intravenous Injection General Anesthesia Drugs Market: Overall Company Footprint Analysis
3.6.1 Intravenous Injection General Anesthesia Drugs Market: Region Footprint
3.6.2 Intravenous Injection General Anesthesia Drugs Market: Company Product Type Footprint
3.6.3 Intravenous Injection General Anesthesia Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 United States VS China VS Rest of the World
4.1 United States VS China: Intravenous Injection General Anesthesia Drugs Production Value Comparison
4.1.1 United States VS China: Intravenous Injection General Anesthesia Drugs Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Intravenous Injection General Anesthesia Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Intravenous Injection General Anesthesia Drugs Production Comparison
4.2.1 United States VS China: Intravenous Injection General Anesthesia Drugs Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Intravenous Injection General Anesthesia Drugs Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Intravenous Injection General Anesthesia Drugs Consumption Comparison
4.3.1 United States VS China: Intravenous Injection General Anesthesia Drugs Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Intravenous Injection General Anesthesia Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Intravenous Injection General Anesthesia Drugs Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Intravenous Injection General Anesthesia Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Intravenous Injection General Anesthesia Drugs Production Value (2019-2024)
4.4.3 United States Based Manufacturers Intravenous Injection General Anesthesia Drugs Production (2019-2024)
4.5 China Based Intravenous Injection General Anesthesia Drugs Manufacturers and Market Share
4.5.1 China Based Intravenous Injection General Anesthesia Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Intravenous Injection General Anesthesia Drugs Production Value (2019-2024)
4.5.3 China Based Manufacturers Intravenous Injection General Anesthesia Drugs Production (2019-2024)
4.6 Rest of World Based Intravenous Injection General Anesthesia Drugs Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Intravenous Injection General Anesthesia Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Intravenous Injection General Anesthesia Drugs Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Intravenous Injection General Anesthesia Drugs Production (2019-2024)
5 Market Analysis by Type
5.1 World Intravenous Injection General Anesthesia Drugs Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Propofol
5.2.2 Sevoflurane
5.2.3 Remifentanil
5.2.4 Etomidate
5.2.5 Isoflurane
5.2.6 Other
5.3 Market Segment by Type
5.3.1 World Intravenous Injection General Anesthesia Drugs Production by Type (2019-2030)
5.3.2 World Intravenous Injection General Anesthesia Drugs Production Value by Type (2019-2030)
5.3.3 World Intravenous Injection General Anesthesia Drugs Average Price by Type (2019-2030)
6 Market Analysis by Application
6.1 World Intravenous Injection General Anesthesia Drugs Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hopitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Intravenous Injection General Anesthesia Drugs Production by Application (2019-2030)
6.3.2 World Intravenous Injection General Anesthesia Drugs Production Value by Application (2019-2030)
6.3.3 World Intravenous Injection General Anesthesia Drugs Average Price by Application (2019-2030)
7 Company Profiles
7.1 Aspen Pharma
7.1.1 Aspen Pharma Details
7.1.2 Aspen Pharma Major Business
7.1.3 Aspen Pharma Intravenous Injection General Anesthesia Drugs Product and Services
7.1.4 Aspen Pharma Intravenous Injection General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Aspen Pharma Recent Developments/Updates
7.1.6 Aspen Pharma Competitive Strengths & Weaknesses
7.2 Fresenius-Kabi
7.2.1 Fresenius-Kabi Details
7.2.2 Fresenius-Kabi Major Business
7.2.3 Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Product and Services
7.2.4 Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Fresenius-Kabi Recent Developments/Updates
7.2.6 Fresenius-Kabi Competitive Strengths & Weaknesses
7.3 AbbVie
7.3.1 AbbVie Details
7.3.2 AbbVie Major Business
7.3.3 AbbVie Intravenous Injection General Anesthesia Drugs Product and Services
7.3.4 AbbVie Intravenous Injection General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 AbbVie Recent Developments/Updates
7.3.6 AbbVie Competitive Strengths & Weaknesses
7.4 Baxter Healthcare
7.4.1 Baxter Healthcare Details
7.4.2 Baxter Healthcare Major Business
7.4.3 Baxter Healthcare Intravenous Injection General Anesthesia Drugs Product and Services
7.4.4 Baxter Healthcare Intravenous Injection General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Baxter Healthcare Recent Developments/Updates
7.4.6 Baxter Healthcare Competitive Strengths & Weaknesses
7.5 B.Braun
7.5.1 B.Braun Details
7.5.2 B.Braun Major Business
7.5.3 B.Braun Intravenous Injection General Anesthesia Drugs Product and Services
7.5.4 B.Braun Intravenous Injection General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 B.Braun Recent Developments/Updates
7.5.6 B.Braun Competitive Strengths & Weaknesses
7.6 Maruishi
7.6.1 Maruishi Details
7.6.2 Maruishi Major Business
7.6.3 Maruishi Intravenous Injection General Anesthesia Drugs Product and Services
7.6.4 Maruishi Intravenous Injection General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Maruishi Recent Developments/Updates
7.6.6 Maruishi Competitive Strengths & Weaknesses
7.7 Piramal
7.7.1 Piramal Details
7.7.2 Piramal Major Business
7.7.3 Piramal Intravenous Injection General Anesthesia Drugs Product and Services
7.7.4 Piramal Intravenous Injection General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Piramal Recent Developments/Updates
7.7.6 Piramal Competitive Strengths & Weaknesses
7.8 Hikma Pharmaceuticals
7.8.1 Hikma Pharmaceuticals Details
7.8.2 Hikma Pharmaceuticals Major Business
7.8.3 Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Product and Services
7.8.4 Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Hikma Pharmaceuticals Recent Developments/Updates
7.8.6 Hikma Pharmaceuticals Competitive Strengths & Weaknesses
7.9 AstraZeneca
7.9.1 AstraZeneca Details
7.9.2 AstraZeneca Major Business
7.9.3 AstraZeneca Intravenous Injection General Anesthesia Drugs Product and Services
7.9.4 AstraZeneca Intravenous Injection General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 AstraZeneca Recent Developments/Updates
7.9.6 AstraZeneca Competitive Strengths & Weaknesses
7.10 Nhwa
7.10.1 Nhwa Details
7.10.2 Nhwa Major Business
7.10.3 Nhwa Intravenous Injection General Anesthesia Drugs Product and Services
7.10.4 Nhwa Intravenous Injection General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Nhwa Recent Developments/Updates
7.10.6 Nhwa Competitive Strengths & Weaknesses
7.11 Hengrui
7.11.1 Hengrui Details
7.11.2 Hengrui Major Business
7.11.3 Hengrui Intravenous Injection General Anesthesia Drugs Product and Services
7.11.4 Hengrui Intravenous Injection General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Hengrui Recent Developments/Updates
7.11.6 Hengrui Competitive Strengths & Weaknesses
7.12 Xi'an Libang
7.12.1 Xi'an Libang Details
7.12.2 Xi'an Libang Major Business
7.12.3 Xi'an Libang Intravenous Injection General Anesthesia Drugs Product and Services
7.12.4 Xi'an Libang Intravenous Injection General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Xi'an Libang Recent Developments/Updates
7.12.6 Xi'an Libang Competitive Strengths & Weaknesses
7.13 Yichang Humanwell
7.13.1 Yichang Humanwell Details
7.13.2 Yichang Humanwell Major Business
7.13.3 Yichang Humanwell Intravenous Injection General Anesthesia Drugs Product and Services
7.13.4 Yichang Humanwell Intravenous Injection General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 Yichang Humanwell Recent Developments/Updates
7.13.6 Yichang Humanwell Competitive Strengths & Weaknesses
7.14 China National Medicines Guorui Pharmaceutical Co.,Ltd.
7.14.1 China National Medicines Guorui Pharmaceutical Co.,Ltd. Details
7.14.2 China National Medicines Guorui Pharmaceutical Co.,Ltd. Major Business
7.14.3 China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Product and Services
7.14.4 China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.14.5 China National Medicines Guorui Pharmaceutical Co.,Ltd. Recent Developments/Updates
7.14.6 China National Medicines Guorui Pharmaceutical Co.,Ltd. Competitive Strengths & Weaknesses
7.15 Maruishi
7.15.1 Maruishi Details
7.15.2 Maruishi Major Business
7.15.3 Maruishi Intravenous Injection General Anesthesia Drugs Product and Services
7.15.4 Maruishi Intravenous Injection General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.15.5 Maruishi Recent Developments/Updates
7.15.6 Maruishi Competitive Strengths & Weaknesses
7.16 Lunan Pharmaceutical Group Corporation
7.16.1 Lunan Pharmaceutical Group Corporation Details
7.16.2 Lunan Pharmaceutical Group Corporation Major Business
7.16.3 Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Product and Services
7.16.4 Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.16.5 Lunan Pharmaceutical Group Corporation Recent Developments/Updates
7.16.6 Lunan Pharmaceutical Group Corporation Competitive Strengths & Weaknesses
8 Industry Chain Analysis
8.1 Intravenous Injection General Anesthesia Drugs Industry Chain
8.2 Intravenous Injection General Anesthesia Drugs Upstream Analysis
8.2.1 Intravenous Injection General Anesthesia Drugs Core Raw Materials
8.2.2 Main Manufacturers of Intravenous Injection General Anesthesia Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Intravenous Injection General Anesthesia Drugs Production Mode
8.6 Intravenous Injection General Anesthesia Drugs Procurement Model
8.7 Intravenous Injection General Anesthesia Drugs Industry Sales Model and Sales Channels
8.7.1 Intravenous Injection General Anesthesia Drugs Sales Model
8.7.2 Intravenous Injection General Anesthesia Drugs Typical Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Intravenous Injection General Anesthesia Drugs Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Intravenous Injection General Anesthesia Drugs Production Value by Region (2019-2024) & (USD Million)
Table 3. World Intravenous Injection General Anesthesia Drugs Production Value by Region (2025-2030) & (USD Million)
Table 4. World Intravenous Injection General Anesthesia Drugs Production Value Market Share by Region (2019-2024)
Table 5. World Intravenous Injection General Anesthesia Drugs Production Value Market Share by Region (2025-2030)
Table 6. World Intravenous Injection General Anesthesia Drugs Production by Region (2019-2024) & (K Units)
Table 7. World Intravenous Injection General Anesthesia Drugs Production by Region (2025-2030) & (K Units)
Table 8. World Intravenous Injection General Anesthesia Drugs Production Market Share by Region (2019-2024)
Table 9. World Intravenous Injection General Anesthesia Drugs Production Market Share by Region (2025-2030)
Table 10. World Intravenous Injection General Anesthesia Drugs Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Intravenous Injection General Anesthesia Drugs Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Intravenous Injection General Anesthesia Drugs Major Market Trends
Table 13. World Intravenous Injection General Anesthesia Drugs Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Intravenous Injection General Anesthesia Drugs Consumption by Region (2019-2024) & (K Units)
Table 15. World Intravenous Injection General Anesthesia Drugs Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Intravenous Injection General Anesthesia Drugs Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Intravenous Injection General Anesthesia Drugs Producers in 2023
Table 18. World Intravenous Injection General Anesthesia Drugs Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Intravenous Injection General Anesthesia Drugs Producers in 2023
Table 20. World Intravenous Injection General Anesthesia Drugs Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Intravenous Injection General Anesthesia Drugs Company Evaluation Quadrant
Table 22. World Intravenous Injection General Anesthesia Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Intravenous Injection General Anesthesia Drugs Production Site of Key Manufacturer
Table 24. Intravenous Injection General Anesthesia Drugs Market: Company Product Type Footprint
Table 25. Intravenous Injection General Anesthesia Drugs Market: Company Product Application Footprint
Table 26. Intravenous Injection General Anesthesia Drugs Competitive Factors
Table 27. Intravenous Injection General Anesthesia Drugs New Entrant and Capacity Expansion Plans
Table 28. Intravenous Injection General Anesthesia Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Intravenous Injection General Anesthesia Drugs Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Intravenous Injection General Anesthesia Drugs Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Intravenous Injection General Anesthesia Drugs Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Intravenous Injection General Anesthesia Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Intravenous Injection General Anesthesia Drugs Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Intravenous Injection General Anesthesia Drugs Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Intravenous Injection General Anesthesia Drugs Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Intravenous Injection General Anesthesia Drugs Production Market Share (2019-2024)
Table 37. China Based Intravenous Injection General Anesthesia Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Intravenous Injection General Anesthesia Drugs Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Intravenous Injection General Anesthesia Drugs Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Intravenous Injection General Anesthesia Drugs Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Intravenous Injection General Anesthesia Drugs Production Market Share (2019-2024)
Table 42. Rest of World Based Intravenous Injection General Anesthesia Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Intravenous Injection General Anesthesia Drugs Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Intravenous Injection General Anesthesia Drugs Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Intravenous Injection General Anesthesia Drugs Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Intravenous Injection General Anesthesia Drugs Production Market Share (2019-2024)
Table 47. World Intravenous Injection General Anesthesia Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Intravenous Injection General Anesthesia Drugs Production by Type (2019-2024) & (K Units)
Table 49. World Intravenous Injection General Anesthesia Drugs Production by Type (2025-2030) & (K Units)
Table 50. World Intravenous Injection General Anesthesia Drugs Production Value by Type (2019-2024) & (USD Million)
Table 51. World Intravenous Injection General Anesthesia Drugs Production Value by Type (2025-2030) & (USD Million)
Table 52. World Intravenous Injection General Anesthesia Drugs Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Intravenous Injection General Anesthesia Drugs Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Intravenous Injection General Anesthesia Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Intravenous Injection General Anesthesia Drugs Production by Application (2019-2024) & (K Units)
Table 56. World Intravenous Injection General Anesthesia Drugs Production by Application (2025-2030) & (K Units)
Table 57. World Intravenous Injection General Anesthesia Drugs Production Value by Application (2019-2024) & (USD Million)
Table 58. World Intravenous Injection General Anesthesia Drugs Production Value by Application (2025-2030) & (USD Million)
Table 59. World Intravenous Injection General Anesthesia Drugs Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Intravenous Injection General Anesthesia Drugs Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Aspen Pharma Basic Information, Manufacturing Base and Competitors
Table 62. Aspen Pharma Major Business
Table 63. Aspen Pharma Intravenous Injection General Anesthesia Drugs Product and Services
Table 64. Aspen Pharma Intravenous Injection General Anesthesia Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Aspen Pharma Recent Developments/Updates
Table 66. Aspen Pharma Competitive Strengths & Weaknesses
Table 67. Fresenius-Kabi Basic Information, Manufacturing Base and Competitors
Table 68. Fresenius-Kabi Major Business
Table 69. Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Product and Services
Table 70. Fresenius-Kabi Intravenous Injection General Anesthesia Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Fresenius-Kabi Recent Developments/Updates
Table 72. Fresenius-Kabi Competitive Strengths & Weaknesses
Table 73. AbbVie Basic Information, Manufacturing Base and Competitors
Table 74. AbbVie Major Business
Table 75. AbbVie Intravenous Injection General Anesthesia Drugs Product and Services
Table 76. AbbVie Intravenous Injection General Anesthesia Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. AbbVie Recent Developments/Updates
Table 78. AbbVie Competitive Strengths & Weaknesses
Table 79. Baxter Healthcare Basic Information, Manufacturing Base and Competitors
Table 80. Baxter Healthcare Major Business
Table 81. Baxter Healthcare Intravenous Injection General Anesthesia Drugs Product and Services
Table 82. Baxter Healthcare Intravenous Injection General Anesthesia Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Baxter Healthcare Recent Developments/Updates
Table 84. Baxter Healthcare Competitive Strengths & Weaknesses
Table 85. B.Braun Basic Information, Manufacturing Base and Competitors
Table 86. B.Braun Major Business
Table 87. B.Braun Intravenous Injection General Anesthesia Drugs Product and Services
Table 88. B.Braun Intravenous Injection General Anesthesia Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. B.Braun Recent Developments/Updates
Table 90. B.Braun Competitive Strengths & Weaknesses
Table 91. Maruishi Basic Information, Manufacturing Base and Competitors
Table 92. Maruishi Major Business
Table 93. Maruishi Intravenous Injection General Anesthesia Drugs Product and Services
Table 94. Maruishi Intravenous Injection General Anesthesia Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Maruishi Recent Developments/Updates
Table 96. Maruishi Competitive Strengths & Weaknesses
Table 97. Piramal Basic Information, Manufacturing Base and Competitors
Table 98. Piramal Major Business
Table 99. Piramal Intravenous Injection General Anesthesia Drugs Product and Services
Table 100. Piramal Intravenous Injection General Anesthesia Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Piramal Recent Developments/Updates
Table 102. Piramal Competitive Strengths & Weaknesses
Table 103. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 104. Hikma Pharmaceuticals Major Business
Table 105. Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Product and Services
Table 106. Hikma Pharmaceuticals Intravenous Injection General Anesthesia Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Hikma Pharmaceuticals Recent Developments/Updates
Table 108. Hikma Pharmaceuticals Competitive Strengths & Weaknesses
Table 109. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 110. AstraZeneca Major Business
Table 111. AstraZeneca Intravenous Injection General Anesthesia Drugs Product and Services
Table 112. AstraZeneca Intravenous Injection General Anesthesia Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. AstraZeneca Recent Developments/Updates
Table 114. AstraZeneca Competitive Strengths & Weaknesses
Table 115. Nhwa Basic Information, Manufacturing Base and Competitors
Table 116. Nhwa Major Business
Table 117. Nhwa Intravenous Injection General Anesthesia Drugs Product and Services
Table 118. Nhwa Intravenous Injection General Anesthesia Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Nhwa Recent Developments/Updates
Table 120. Nhwa Competitive Strengths & Weaknesses
Table 121. Hengrui Basic Information, Manufacturing Base and Competitors
Table 122. Hengrui Major Business
Table 123. Hengrui Intravenous Injection General Anesthesia Drugs Product and Services
Table 124. Hengrui Intravenous Injection General Anesthesia Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Hengrui Recent Developments/Updates
Table 126. Hengrui Competitive Strengths & Weaknesses
Table 127. Xi'an Libang Basic Information, Manufacturing Base and Competitors
Table 128. Xi'an Libang Major Business
Table 129. Xi'an Libang Intravenous Injection General Anesthesia Drugs Product and Services
Table 130. Xi'an Libang Intravenous Injection General Anesthesia Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. Xi'an Libang Recent Developments/Updates
Table 132. Xi'an Libang Competitive Strengths & Weaknesses
Table 133. Yichang Humanwell Basic Information, Manufacturing Base and Competitors
Table 134. Yichang Humanwell Major Business
Table 135. Yichang Humanwell Intravenous Injection General Anesthesia Drugs Product and Services
Table 136. Yichang Humanwell Intravenous Injection General Anesthesia Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 137. Yichang Humanwell Recent Developments/Updates
Table 138. Yichang Humanwell Competitive Strengths & Weaknesses
Table 139. China National Medicines Guorui Pharmaceutical Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 140. China National Medicines Guorui Pharmaceutical Co.,Ltd. Major Business
Table 141. China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Product and Services
Table 142. China National Medicines Guorui Pharmaceutical Co.,Ltd. Intravenous Injection General Anesthesia Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 143. China National Medicines Guorui Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 144. China National Medicines Guorui Pharmaceutical Co.,Ltd. Competitive Strengths & Weaknesses
Table 145. Maruishi Basic Information, Manufacturing Base and Competitors
Table 146. Maruishi Major Business
Table 147. Maruishi Intravenous Injection General Anesthesia Drugs Product and Services
Table 148. Maruishi Intravenous Injection General Anesthesia Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 149. Maruishi Recent Developments/Updates
Table 150. Lunan Pharmaceutical Group Corporation Basic Information, Manufacturing Base and Competitors
Table 151. Lunan Pharmaceutical Group Corporation Major Business
Table 152. Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Product and Services
Table 153. Lunan Pharmaceutical Group Corporation Intravenous Injection General Anesthesia Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 154. Global Key Players of Intravenous Injection General Anesthesia Drugs Upstream (Raw Materials)
Table 155. Intravenous Injection General Anesthesia Drugs Typical Customers
Table 156. Intravenous Injection General Anesthesia Drugs Typical Distributors
List of Figure
Figure 1. Intravenous Injection General Anesthesia Drugs Picture
Figure 2. World Intravenous Injection General Anesthesia Drugs Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Intravenous Injection General Anesthesia Drugs Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Intravenous Injection General Anesthesia Drugs Production (2019-2030) & (K Units)
Figure 5. World Intravenous Injection General Anesthesia Drugs Average Price (2019-2030) & (US$/Unit)
Figure 6. World Intravenous Injection General Anesthesia Drugs Production Value Market Share by Region (2019-2030)
Figure 7. World Intravenous Injection General Anesthesia Drugs Production Market Share by Region (2019-2030)
Figure 8. North America Intravenous Injection General Anesthesia Drugs Production (2019-2030) & (K Units)
Figure 9. Europe Intravenous Injection General Anesthesia Drugs Production (2019-2030) & (K Units)
Figure 10. China Intravenous Injection General Anesthesia Drugs Production (2019-2030) & (K Units)
Figure 11. Japan Intravenous Injection General Anesthesia Drugs Production (2019-2030) & (K Units)
Figure 12. Intravenous Injection General Anesthesia Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Intravenous Injection General Anesthesia Drugs Consumption (2019-2030) & (K Units)
Figure 15. World Intravenous Injection General Anesthesia Drugs Consumption Market Share by Region (2019-2030)
Figure 16. United States Intravenous Injection General Anesthesia Drugs Consumption (2019-2030) & (K Units)
Figure 17. China Intravenous Injection General Anesthesia Drugs Consumption (2019-2030) & (K Units)
Figure 18. Europe Intravenous Injection General Anesthesia Drugs Consumption (2019-2030) & (K Units)
Figure 19. Japan Intravenous Injection General Anesthesia Drugs Consumption (2019-2030) & (K Units)
Figure 20. South Korea Intravenous Injection General Anesthesia Drugs Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Intravenous Injection General Anesthesia Drugs Consumption (2019-2030) & (K Units)
Figure 22. India Intravenous Injection General Anesthesia Drugs Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Intravenous Injection General Anesthesia Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Intravenous Injection General Anesthesia Drugs Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Intravenous Injection General Anesthesia Drugs Markets in 2023
Figure 26. United States VS China: Intravenous Injection General Anesthesia Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Intravenous Injection General Anesthesia Drugs Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Intravenous Injection General Anesthesia Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Intravenous Injection General Anesthesia Drugs Production Market Share 2023
Figure 30. China Based Manufacturers Intravenous Injection General Anesthesia Drugs Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Intravenous Injection General Anesthesia Drugs Production Market Share 2023
Figure 32. World Intravenous Injection General Anesthesia Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Intravenous Injection General Anesthesia Drugs Production Value Market Share by Type in 2023
Figure 34. Propofol
Figure 35. Sevoflurane
Figure 36. Remifentanil
Figure 37. Etomidate
Figure 38. Isoflurane
Figure 39. Other
Figure 40. World Intravenous Injection General Anesthesia Drugs Production Market Share by Type (2019-2030)
Figure 41. World Intravenous Injection General Anesthesia Drugs Production Value Market Share by Type (2019-2030)
Figure 42. World Intravenous Injection General Anesthesia Drugs Average Price by Type (2019-2030) & (US$/Unit)
Figure 43. World Intravenous Injection General Anesthesia Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 44. World Intravenous Injection General Anesthesia Drugs Production Value Market Share by Application in 2023
Figure 45. Hopitals
Figure 46. Clinics
Figure 47. Others
Figure 48. World Intravenous Injection General Anesthesia Drugs Production Market Share by Application (2019-2030)
Figure 49. World Intravenous Injection General Anesthesia Drugs Production Value Market Share by Application (2019-2030)
Figure 50. World Intravenous Injection General Anesthesia Drugs Average Price by Application (2019-2030) & (US$/Unit)
Figure 51. Intravenous Injection General Anesthesia Drugs Industry Chain
Figure 52. Intravenous Injection General Anesthesia Drugs Procurement Model
Figure 53. Intravenous Injection General Anesthesia Drugs Sales Model
Figure 54. Intravenous Injection General Anesthesia Drugs Sales Channels, Direct Sales, and Distribution
Figure 55. Methodology
Figure 56. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Aspen Pharma Fresenius-Kabi AbbVie Baxter Healthcare B.Braun Maruishi Piramal Hikma Pharmaceuticals AstraZeneca Nhwa Hengrui Xi'an Libang Yichang Humanwell China National Medicines Guorui Pharmaceutical Co.,Ltd. Maruishi Lunan Pharmaceutical Group Corporation
Related Reports
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
-
- Digging deeper into global industry information and providing market strategies.Contact Us >>